Australian health tech industries unite in criticism of reforms blueprint
This article was originally published in Clinica
Executive Summary
Australia’s medical technology and biotechnology industries have expressed disappointment and concern at a government “blueprint” for reforms designed to improve the transparency and effectiveness of healthcare product regulation.